Table 2.
Clinical data and risk factors for coronary disease in 57 patients undergoing on-pump CABG.
| CHO (n=14) | Control (n=14) | CHO+W3 (n=15) | W3 (n=14) | P-value | |
|---|---|---|---|---|---|
| LVEF | 0.55±0.12 (0.60) | 0.57±0.11 (0.60) | 0.54±0.13 (0.60) | 0.62±0.11 (0.65) | 0.168K |
| Smoking | 6 (43) | 9 (64) | 7 (47) | 8 (57) | 0.653Q |
| Diabetes | 4 (29) | 3 (21) | 5 (33) | 6 (43) | 0.666Q |
| Dyslipidemia | 11 (79) | 12 (86) | 8 (53) | 11 (79) | 0.204Q |
| Previous AMI | 7 (50) | 9 (64) | 6 (40) | 7 (50) | 0.631Q |
| Use of beta blockers | 9 (64) | 10 (71) | 6 (40) | 11 (79) | 0.151Q |
| Use of statins | 11 (79) | 11 (79) | 9 (60) | 11 (79) | 0.580Q |
| Use of fibrates | 2 (14) | 2 (14) | 2 (13) | 3 (21) | 0.930Q |
| Previous angioplasty | 1 (7) | 4 (29) | 4 (27) | 3 (21) | 0.495Q |
K
Kruskal-Wallis;
Q
Chi-square
AMI=acute myocardial infarction; CHO group = fasting abbreviation with carbohydrate; CHO+W3 group = fasting abbreviation with carbohydrate and perioperative infusion of ω-3 PUFA; Control group = fasting abbreviation with water; LVEF=left ventricular ejection fraction; n=number; P=probability; W3 group = fasting abbreviation with water and perioperative infusion of ω-3 PUFA
Data expressed as mean ± standard deviation; median in parentheses for continuous variables or number (%) for categorical variables.